🇺🇸 Ustekinumab and Upadacitinib in United States

Ustekinumab and Upadacitinib (Ustekinumab and Upadacitinib) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Ustekinumab and Upadacitinib in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ustekinumab and Upadacitinib approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ustekinumab and Upadacitinib in United States?

Sixth Affiliated Hospital, Sun Yat-sen University is the originator. The local marketing authorisation holder may differ — check the official source linked above.